Pharmacogenomics

The pharmacogenomics research team focuses on understanding how genetic and regulatory variability influences individual responses to pharmacological treatments. By identifying genetic and regulatory variants associated with drug efficacy and adverse drug reactions, the group aims to support the development of personalized therapeutic strategies and improve drug safety and effectiveness. These activities contribute to the advancement of precision medicine, bridging genomic insights with clinical decision-making.